The Motley Fool4d
Vertex Pharma Just Scored a Major FDA Approval. Is the Stock a No-Brainer Buy Now?
Vertex just won approval for a drug to treat one of the most common health problems -- pain. The biotech company is offering an option for patients and doctors who don’t want to go for ...
The Motley Fool6d
Is Vertex Pharmaceuticals a Buy Now That the FDA Approved Its New Pain Drug?
The U.S. Food and Drug Administration approved a new prescription-strength pain reliever from Vertex Pharmaceuticals on Jan. 30, 2025. Journavx is a non-opioid drug that prevents peripheral nerves ...
STAT5d
The first shot taken at Medicaid, and Optum’s wellness visit ad
UnitedHealthcare likely to cover Vertex’s pain drug Vertex Pharmaceuticals received FDA approval for a new non-opioid pain drug, marketed as Journavx, and it appears the nation’s largest ...
Yahoo Finance4d
Vertex Pharmaceuticals Incorporated (VRTX)
Get prepared with the key expectations. Vertex Pharmaceuticals (NASDAQ: VRTX) has long been known as the company to turn to for life-saving cystic fibrosis (CF) drugs, and this platform has helped ...
The Hindu4d
No power supply in some areas in Mangaluru on Feb. 5
There will be no power supply to some areas in Mangaluru on February 5 from 10 a.m. to 5 p.m. The areas are Bejai Main Road, Bejai New Road, Bejai Church Road, MCF Colony, Anegundi, Sankaigudda ...